We provide investors in healthcare, social care and pharmaceuticals with reimbursement and regulatory due diligence services through a detailed national and local level policy analysis.  Our clients receive seamless, bespoke analysis that highlight the key policy and reimbursement issues impacting a transaction.  This analysis extends beyond the happenings at Whitehall and includes Local Authorities, the Scotland Parliament, the Welsh Assembly and Northern Ireland Assembly, STP and CCG planning.

Our UK Transaction Advisory team is comprised of individuals with experience from the Department of Health, NHS England, Care Quality Commission and Local Authorities.